Oxford Cancer Analytics Ltd was incorporated on 3 February 2020 and is registered at Inventa, Oxford, OX2 0HA. The company is active and operates as a private limited company. Its registered SIC codes point to two areas: research and experimental development on biotechnology (72110) and other human health activities (86900). This indicates the business is engaged in scientific research with a health-oriented focus, likely in the field of cancer diagnostics, treatment, or drug discovery. As a cancer analytics company, its work probably combines biological data, computational methods, and clinical insights to support oncology research or patient care. The company holds a Skilled Worker sponsor licence with an A rating, which allows it to employ non-UK workers in eligible roles. This suggests it has active or planned hiring needs for skilled staff, and it can offer certificates of sponsorship to successful applicants. The exact number of employees is not public information, but given the company's recent incorporation and the typical size of biotechnology startups, it is likely a small enterprise. There is no confirmed international presence; the registered office is in the UK, and while the company may collaborate globally, that is not verified. The focus on cancer analytics places it within a rapidly evolving sector where data-driven approaches are increasingly important. The combination of biotechnology research and human health activities suggests work that could range from biomarker identification to clinical decision support. No further details are available from public sources at this time.

Oxford Cancer Analytics Ltd was incorporated on 3 February 2020 and is registered at Inventa, Oxford, OX2 0HA. The company is active and operates as a private limited company. Its registered SIC codes point to two areas: research and experimental development on biotechnology (72110) and other human health activities (86900). This indicates the business is engaged in scientific research with a health-oriented focus, likely in the field of cancer diagnostics, treatment, or drug discovery. As a cancer analytics company, its work probably combines biological data, computational methods, and clinical insights to support oncology research or patient care. The company holds a Skilled Worker sponsor licence with an A rating, which allows it to employ non-UK workers in eligible roles. This suggests it has active or planned hiring needs for skilled staff, and it can offer certificates of sponsorship to successful applicants. The exact number of employees is not public information, but given the company's recent incorporation and the typical size of biotechnology startups, it is likely a small enterprise. There is no confirmed international presence; the registered office is in the UK, and while the company may collaborate globally, that is not verified. The focus on cancer analytics places it within a rapidly evolving sector where data-driven approaches are increasingly important. The combination of biotechnology research and human health activities suggests work that could range from biomarker identification to clinical decision support. No further details are available from public sources at this time.